Monte Rosa Stock Forward View - Simple Regression
| GLUE Stock | USD 21.36 0.23 1.09% |
Monte Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Monte Rosa stock prices and determine the direction of Monte Rosa Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Monte Rosa's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The value of RSI of Monte Rosa's share price is at 56. This usually indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Monte Rosa, making its price go up or down. Momentum 56
Buy Extended
Oversold | Overbought |
Using Monte Rosa hype-based prediction, you can estimate the value of Monte Rosa Therapeutics from the perspective of Monte Rosa response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Monte Rosa Therapeutics on the next trading day is expected to be 23.29 with a mean absolute deviation of 1.54 and the sum of the absolute errors of 93.99. Monte Rosa after-hype prediction price | USD 21.36 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Monte Rosa to cross-verify your projections. Monte Rosa Additional Predictive Modules
Most predictive techniques to examine Monte price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Monte using various technical indicators. When you analyze Monte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Monte Rosa Simple Regression Price Forecast For the 30th of January
Given 90 days horizon, the Simple Regression forecasted value of Monte Rosa Therapeutics on the next trading day is expected to be 23.29 with a mean absolute deviation of 1.54, mean absolute percentage error of 4.08, and the sum of the absolute errors of 93.99.Please note that although there have been many attempts to predict Monte Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Monte Rosa's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Monte Rosa Stock Forecast Pattern
| Backtest Monte Rosa | Monte Rosa Price Prediction | Buy or Sell Advice |
Monte Rosa Forecasted Value
In the context of forecasting Monte Rosa's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Monte Rosa's downside and upside margins for the forecasting period are 15.65 and 30.92, respectively. We have considered Monte Rosa's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Monte Rosa stock data series using in forecasting. Note that when a statistical model is used to represent Monte Rosa stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 119.5166 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.5408 |
| MAPE | Mean absolute percentage error | 0.0861 |
| SAE | Sum of the absolute errors | 93.9859 |
Predictive Modules for Monte Rosa
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Monte Rosa Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Monte Rosa's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Monte Rosa After-Hype Price Density Analysis
As far as predicting the price of Monte Rosa at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Monte Rosa or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Monte Rosa, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Monte Rosa Estimiated After-Hype Price Volatility
In the context of predicting Monte Rosa's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Monte Rosa's historical news coverage. Monte Rosa's after-hype downside and upside margins for the prediction period are 13.73 and 28.99, respectively. We have considered Monte Rosa's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Monte Rosa is slightly risky at this time. Analysis and calculation of next after-hype price of Monte Rosa Therapeutics is based on 3 months time horizon.
Monte Rosa Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Monte Rosa is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Monte Rosa backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Monte Rosa, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.08 | 7.63 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
21.36 | 21.36 | 0.00 |
|
Monte Rosa Hype Timeline
Monte Rosa Therapeutics is currently traded for 21.36. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Monte is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 1.08%. %. The volatility of related hype on Monte Rosa is about 0.0%, with the expected price after the next announcement by competition of 21.36. About 94.0% of the company shares are owned by institutional investors. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in a few days. Check out Historical Fundamental Analysis of Monte Rosa to cross-verify your projections.Monte Rosa Related Hype Analysis
Having access to credible news sources related to Monte Rosa's direct competition is more important than ever and may enhance your ability to predict Monte Rosa's future price movements. Getting to know how Monte Rosa's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Monte Rosa may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DAWN | Day One Biopharmaceuticals | 0.00 | 0 per month | 3.73 | 0.12 | 13.81 | (6.53) | 39.62 | |
| ARVN | Arvinas | 0.00 | 0 per month | 3.27 | 0.11 | 5.91 | (5.07) | 28.90 | |
| REPL | Replimune Group | 0.00 | 0 per month | 0.00 | (0.14) | 4.82 | (5.32) | 14.00 | |
| TBPH | Theravance Biopharma | 0.00 | 0 per month | 2.19 | 0.12 | 3.74 | (3.89) | 28.70 | |
| AVBP | ArriVent BioPharma Common | 0.00 | 0 per month | 3.13 | 0.08 | 6.71 | (6.03) | 18.12 | |
| GERN | Geron | 0.00 | 0 per month | 2.94 | 0.04 | 6.72 | (4.76) | 16.99 | |
| VIR | Vir Biotechnology | 0.00 | 0 per month | 3.47 | 0.10 | 8.08 | (6.04) | 20.46 | |
| DNA | Ginkgo Bioworks Holdings | 0.00 | 0 per month | 0.00 | (0.10) | 5.39 | (6.79) | 20.80 | |
| VALN | Valneva SE ADR | 0.00 | 0 per month | 2.42 | 0 | 4.83 | (4.81) | 15.59 | |
| MGTX | MeiraGTx Holdings PLC | 0.00 | 0 per month | 0.00 | (0.08) | 5.08 | (5.18) | 14.00 |
Other Forecasting Options for Monte Rosa
For every potential investor in Monte, whether a beginner or expert, Monte Rosa's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Monte Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Monte. Basic forecasting techniques help filter out the noise by identifying Monte Rosa's price trends.Monte Rosa Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Monte Rosa stock to make a market-neutral strategy. Peer analysis of Monte Rosa could also be used in its relative valuation, which is a method of valuing Monte Rosa by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Monte Rosa Market Strength Events
Market strength indicators help investors to evaluate how Monte Rosa stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Monte Rosa shares will generate the highest return on investment. By undertsting and applying Monte Rosa stock market strength indicators, traders can identify Monte Rosa Therapeutics entry and exit signals to maximize returns.
Monte Rosa Risk Indicators
The analysis of Monte Rosa's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Monte Rosa's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting monte stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.46 | |||
| Semi Deviation | 3.8 | |||
| Standard Deviation | 7.63 | |||
| Variance | 58.28 | |||
| Downside Variance | 18.79 | |||
| Semi Variance | 14.41 | |||
| Expected Short fall | (5.37) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Monte Rosa
The number of cover stories for Monte Rosa depends on current market conditions and Monte Rosa's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Monte Rosa is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Monte Rosa's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Monte Rosa Short Properties
Monte Rosa's future price predictability will typically decrease when Monte Rosa's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Monte Rosa Therapeutics often depends not only on the future outlook of the potential Monte Rosa's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Monte Rosa's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 73.9 M | |
| Cash And Short Term Investments | 372.1 M |
Check out Historical Fundamental Analysis of Monte Rosa to cross-verify your projections. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Will Stock sector continue expanding? Could Monte diversify its offerings? Factors like these will boost the valuation of Monte Rosa. Market participants price Monte higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Monte Rosa data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Monte Rosa Therapeutics's market price often diverges from its book value, the accounting figure shown on Monte's balance sheet. Smart investors calculate Monte Rosa's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Monte Rosa's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Monte Rosa's value and its price as these two are different measures arrived at by different means. Investors typically determine if Monte Rosa is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monte Rosa's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.